Navigation Links
AAPM statement on DEA ruling allowing multiple prescriptions for controlled substances
Date:11/19/2007

GLENVIEW, Ill. The American Academy of Pain Medicine (AAPM) supports todays Drug Enforcement Administration (DEA) ruling, which allows multiple prescriptions for controlled substances when appropriate. This DEA Final Ruling, Issuance of Multiple Prescriptions for Schedule II Controlled Substances, was published in the Federal Register on Monday, Nov. 19, 2007.

AAPM considers this ruling to be a positive indication of recently improved communication between the medical community and law enforcement. Under protest from pain physicians, the DEA had previously disallowed Do Not Fill Until prescriptions for several years. The agencys Final Rule has been eagerly awaited by these concerned physicians who must provide legitimate pain control.

Although not in effect until 30 days from the date of the final ruling on Issuance of Multiple Prescriptions for Schedule II Controlled Substances, this rule change allows physicians to write three separate prescriptions with staggered fill dates. Patients can still be given the equivalent of a 90-day prescription for schedule II controlled substances when medically appropriate. Schedule II drugs are those that have recognized medical uses as well as a potential for dependence and abuse. Consequently, these drugs are carefully controlled and regulated by the DEA.

This welcome policy reversal by the DEA has eliminated the burden previously imposed on patients with cancer or chronic pain who were forced to visit their physician every month for new pain medicine prescriptions when there was no medical necessity to do so. The DEA now allows physicians to use their professional judgment to carefully control the amount of a controlled substance issued to a patient at one time. Do Not Fill Until prescriptions offer increased control, safety and convenience, and may be issued in small increments for at-risk patients, or by the month to comply with insurance reimbursement regulations.

With todays Final Rule, the DEA has recognized the need for policies that support effective control of potentially abusable drugs that do not unnecessarily hinder the appropriate treatment of pain. On behalf of all legitimate patients with pain, AAPM continues to address and debate policies that address the dual crises of prescription drug abuse and undertreated pain. AAPM is committed to safe and effective treatment of pain and to effective policy on prescription drug abuse.


'/>"/>

Contact: Amy Jenkins
amy@jenkinspr.com
312-371-8365
American Academy of Pain Medicine
Source:Eurekalert

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
3. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
4. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
5. Statement by Oscar S. Wyatt, Jr.
6. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
7. Pelosi Statement on Proposed Entitlement Task Force
8. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
9. Statement on House/Senate Agreement on SCHIP Legislation
10. Statement from the Alliance for Quality Nursing Home Care
11. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... January 20, 2017 , ... ... enhance people’s everyday lives, recently attended the January ECRM Trade Show in Hilton ... is known for its large range of supplements that keep the body functioning ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the ... an educator interacting with countless women who had little knowledge of the female characters ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Christmas in Suffolk”: ... published author, Sara Seymour, who lives in Lafayette, Indiana where she works in a ... iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new book ...
(Date:1/19/2017)... (PRWEB) , ... January 20, 2017 , ... Today, the ... to participate in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who ... patients. APMs are an important part of the Administration’s effort to build a ...
(Date:1/19/2017)... , ... January 19, 2017 , ... This month, the ... that the name of their drug rehab center in Delray Beach, Florida has been ... that not only stars such as Philip Seymour Hoffman and Chris Farley are dying ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... 2017 According to a study conducted by ... to witness a CAGR of 6.5% during the forecast period 2016-2024. ... continue to be the leading market for cryotherapy globally during the ... Highlights ... ensuring affordable and adequate supply of gas in order to provide ...
Breaking Medicine Technology: